{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:13:02Z","timestamp":1780567982721,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373186"],"award-info":[{"award-number":["81373186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.intimp.2021.107563","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T04:42:21Z","timestamp":1617252141000},"page":"107563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Iguratimod ameliorates nephritis by modulating the Th17\/Treg paradigm in pristane-induced lupus"],"prefix":"10.1016","volume":"96","author":[{"given":"Yuan","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107563_b0005","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107563_b0010","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2009080805","article-title":"Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis","volume":"21","author":"Yung","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2021.107563_b0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1358\/dot.2012.48.9.1855758","article-title":"Iguratimod: a new disease-modifying antirheumatic drug","volume":"48","author":"Mucke","year":"2012","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.intimp.2021.107563_b0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jjp.67.305","article-title":"T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts","volume":"67","author":"Tanaka","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107563_b0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/1744666X.2015.1027151","article-title":"Iguratimod for the treatment of rheumatoid arthritis in Japan","volume":"11","author":"Tanaka","year":"2015","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13075-020-02204-0","article-title":"The effect of nicotinamide adenine dinucleotide phosphate oxidase 4 on migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"22","author":"Lee","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2021.107563_b0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/PL00000291","article-title":"An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation","volume":"51","author":"Aikawa","year":"2002","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2021.107563_b0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.intimp.2016.03.038","article-title":"Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-kappaB and MAPK pathways","volume":"35","author":"Gan","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.107563_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/356040","article-title":"Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis","volume":"2015","author":"Xu","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2021.107563_b0050","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.1300832","article-title":"A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide","volume":"191","author":"Luo","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-006-0542-y","article-title":"Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study","volume":"17","author":"Hara","year":"2007","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107563_b0060","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/rheumatology\/keg381","article-title":"Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice","volume":"42","author":"Tanaka","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2021.107563_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108273","article-title":"Prevention of immune nephritis by the small molecular weight immunomodulator iguratimod in MRL\/lpr mice","volume":"9","author":"Yan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2021.107563_b0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2021.107563_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","article-title":"T cells in Systemic Lupus Erythematosus","volume":"43","author":"Suarez-Fueyo","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0080","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fimmu.2015.00610","article-title":"Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus","volume":"6","author":"Rother","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0085","doi-asserted-by":"crossref","unstructured":"K. Mannoor, M.A., Y. Xu, M. Beardall, C. Chen, Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival, J. Immunol. 188 (2012) 10.","DOI":"10.4049\/jimmunol.1102859"},{"key":"10.1016\/j.intimp.2021.107563_b0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.omtn.2018.02.010","article-title":"MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL\/lpr Mice","volume":"11","author":"Xia","year":"2018","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.intimp.2021.107563_b0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41467-018-02890-0","article-title":"IL-6\/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2021.107563_b0100","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1681\/ASN.2012010040","article-title":"IL-17A production by renal gammadelta T cells promotes kidney injury in crescentic GN","volume":"23","author":"Turner","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2021.107563_b0105","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.12.1087","article-title":"Current and novel therapeutics in the treatment of systemic lupus erythematosus","volume":"127","author":"Yildirim-Toruner","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/intimm\/dxt054","article-title":"Mycophenolic acid-treated dendritic cells generate regulatory CD4+ T cells that suppress CD8+ T cells' allocytotoxicity","volume":"26","author":"Kazma","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0120","doi-asserted-by":"crossref","unstructured":"TM., Y. S. N. C. H. S. C. K. C. K. Z. Q. C. M. C.: Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-\u03b21 and collagen synthesis, J. Autoimmun., 2015; Apr: 111-122.","DOI":"10.1016\/j.jaut.2015.01.008"},{"key":"10.1016\/j.intimp.2021.107563_b0125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2021.107563_b0130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrrheum.2015.69","article-title":"The anti-DNA antibody: origin and impact, dogmas and controversies","volume":"11","author":"Rekvig","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107563_b0135","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/art.20862","article-title":"Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential","volume":"52","author":"Zhao","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2021.107563_b0140","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00296-017-3733-2","article-title":"Treatment for lupus nephritis: an overview of systematic reviews and meta-analyses","volume":"37","author":"Chen","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2021.107563_b0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2015.00475","article-title":"Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies","volume":"6","author":"Yung","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0150","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","article-title":"Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13075-019-1874-2","article-title":"Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC\/EGR1 axis","volume":"21","author":"Ye","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2021.107563_b0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0165","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crispin","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0170","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","article-title":"The role of IL-23\/IL-17 axis in lupus nephritis","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107563_b0175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10875-011-9637-0","article-title":"Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis","volume":"32","author":"Edelbauer","year":"2012","journal-title":"J. Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T18:52:58Z","timestamp":1727290378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"alternative-id":["S1567576921001995"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107563","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iguratimod ameliorates nephritis by modulating the Th17\/Treg paradigm in pristane-induced lupus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107563"}}